Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
